It is essential to clarify that while Ozempic and Mounjaro offer substantial benefits, they require adherence, lifestyle modification, and ongoing monitoring
Lilly remains confident in the differentiated benefits of tirzepatide, the first and only dual GIP/GLP-1 receptor agonist approved to treat adults with obesity and adults with type two diabetes, the company said in an email statement to The Canadian Press
2 Moreover, for a person with type 2 diabetes (T2DM), rates of death in the year following HF admission are 2-5 times higher than that of the general population
Beneficios cardiovasculares El estudio SUSTAIN-6 demostr que la semaglutida inyectable (Ozempic) reduce significativamente el riesgo de eventos cardiovasculares mayores en pacientes con diabetes tipo 2 y enfermedad cardiovascular establecida
This dosage is 1 tablet in the first week and then slowly increasing, to achieve two tablets daily